PHARMA MAR, S.A. «...1112131415...» Page 13 out of 21 25/06/2021 14:30 PHARMA MAR, S.A. Liquidity and counterparty agreements The Company announces the termination of the liquidity agreement entered into on June, 4, 2018 with JB Capital Markets, Sociedad de Valores, S.A.U. Register number: 10195 20/05/2021 14:50 PHARMA MAR, S.A. General Shareholders’ Meeting Regulations La sociedad remite el Reglamento de la junta general de accionistas Register number: 9527 05/05/2021 08:23 PHARMA MAR, S.A. On business and financial situation The Company files first quarter 2021 financial information. Register number: 9162 29/04/2021 13:27 PHARMA MAR, S.A. On business and financial situation The Company announces that it has obtained the authorization from the Spanish Agency for Medicines and Health Products (AEMPS) to initiate the Phase III NEPTUNO. Register number: 9011 23/04/2021 08:24 PHARMA MAR, S.A. On business and financial situation The Company announces its licensing partner, Specialised Therapeutics Asia, Pte. Ltd. (STA) received marketing approval for Yondelis® (trabectedin) by the Australian Therapeutic Goods Administration (TGA). Register number: 8811 15/04/2021 14:35 PHARMA MAR, S.A. On corporate governance The Company reports changes in the composition of its Board of Directors and of its Appointments and Compensation and Sustainability Committee. Register number: 8665 15/04/2021 13:55 PHARMA MAR, S.A. Other relevant information The Company informs about the dividend payment. Register number: 8663 15/04/2021 13:52 PHARMA MAR, S.A. Announcement of general shareholders’ meeting It is reported that all proposed resolutions submitted by the Board to the General Shareholders’ Meeting have been approved. Register number: 8662 15/04/2021 11:45 PHARMA MAR, S.A. Announcement of general shareholders’ meeting Attached is a copy of the presentation to shareholders to be made at the General Shareholders’ Meeting of Pharma Mar by the Chairman of the Company. Register number: 8657 08/04/2021 17:45 PHARMA MAR, S.A. Liquidity and counterparty agreements The Company reports details of the operations of the Liquidity Agreement between 01/01/2021 and 31/03/2021 Register number: 8484 Page 13 out of 21 «...1112131415...»